Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer

[1]  P. Lind,et al.  Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine. , 2005, Thyroid : official journal of the American Thyroid Association.

[2]  W. Stronegger,et al.  Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. , 2004, Thyroid : official journal of the American Thyroid Association.

[3]  L. Duntas,et al.  Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. , 2004, European journal of endocrinology.

[4]  H. Stettner,et al.  Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. , 2003, Surgery.

[5]  G. Kumnig.  Stellenwert der F‐18‐Fluorodeoxy‐Glukose‐Positronenemissionstomographie beim Schilddrüsenkarzinom , 2002 .

[6]  P. Mikosch,et al.  Results of preoperative ultrasound guided fine needle aspiration biopsy of solitary thyroid nodules as compared with the histology , 2001, Nuklearmedizin.

[7]  S. Reske,et al.  FDG-PET for clinical use , 2001, European Journal of Nuclear Medicine.

[8]  P. Mikosch,et al.  Scintigraphic and ultrasonographic appearance in different tumor stages of thyroid carcinoma. , 2000, Acta medica Austriaca.

[9]  P. Mikosch,et al.  Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area , 2000, European Journal of Nuclear Medicine.

[10]  P. Lind.  131I whole body scintigraphy in thyroid cancer patients. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[11]  P. Lind.  Multi-tracer imaging of thyroid nodules: is there a role in the preoperative assessment of nodular goiter? , 1999, European Journal of Nuclear Medicine.

[12]  W. Langsteger,et al.  Epidemiology of thyroid diseases in iodine sufficiency. , 1998, Thyroid : official journal of the American Thyroid Association.

[13]  M. Dietlein,et al.  Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer , 1997, European Journal of Nuclear Medicine.

[14]  P. Mikosch,et al.  Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy , 1997, European Journal of Nuclear Medicine.

[15]  J. Ruhlmann,et al.  Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. , 1997, Thyroid : official journal of the American Thyroid Association.

[16]  W. Langsteger,et al.  Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Hanke,et al.  Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Ferdeghini,et al.  Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. , 1995, Thyroid : official journal of the American Thyroid Association.

[19]  A. Avraham,et al.  Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  H. Gharib,et al.  Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. , 1993, Clinics in laboratory medicine.

[21]  S. Kohlfuerst,et al.  Radioiodine Therapy: Malignant Thyroid Disease , 2007 .

[22]  S. Reske,et al.  FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. , 2001, European journal of nuclear medicine.

[23]  T. Petrich,et al.  Follow-up of thyroid cancer patients using rhTSH -preliminary results , 2001, Nuklearmedizin.

[24]  P. Mikosch,et al.  Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.